Zacks Investment Research upgraded shares of Koninklijke DSM (OTCMKTS:RDSMY) from a hold rating to a buy rating in a report issued on Thursday. The firm currently has $27.00 price objective on the basic materials company’s stock.

According to Zacks, “DSM N V ADR is involved in the Chemicals Industry. Their main focus is on base materials, performance materials, materials processing, base chemicals and fine chemicals and coating resins. They are also involved in the exploration and development of oil and natural gas deposits in the North Sea, as well as the licensing of chemical technology and know-how; in addition the company produces ingredients for bakery products. DSM is a world market leader in a number of products, including caprolactam, melamine and EPDM synthetic rubber. “

Several other research firms have also recently weighed in on RDSMY. ValuEngine cut Koninklijke DSM from a buy rating to a hold rating in a research report on Friday, December 1st. Deutsche Bank raised Koninklijke DSM from a hold rating to a buy rating in a research report on Friday, December 1st. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company currently has an average rating of Buy and a consensus price target of $27.00.

Koninklijke DSM (OTCMKTS RDSMY) traded up $0.08 during mid-day trading on Thursday, reaching $24.70. The company’s stock had a trading volume of 24,082 shares, compared to its average volume of 30,212. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.11 and a current ratio of 1.74. Koninklijke DSM has a twelve month low of $14.78 and a twelve month high of $24.43. The stock has a market capitalization of $17,584.20, a PE ratio of 30.29, a P/E/G ratio of 2.75 and a beta of 1.26.

ILLEGAL ACTIVITY WARNING: “Koninklijke DSM (RDSMY) Upgraded to Buy at Zacks Investment Research” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://www.watchlistnews.com/koninklijke-dsm-rdsmy-upgraded-to-buy-at-zacks-investment-research/1795852.html.

Koninklijke DSM Company Profile

Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company’s segments include Nutrition, Performance Materials, Innovation Center and Corporate Activities. Its Nutrition segment includes DSM Nutritional Products and DSM Food Specialties.

Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with MarketBeat.com's FREE daily email newsletter.